Our study is supported by several other studies in which Notch silencing inhibited the NF-κB pathway in prostate cancer cells, pancreatic cancer cells and endothelial cells under inflammatory condition (Quillard et al., 2010; Wang et al., 2009; Zhang et al., 2017). This evidence concerns the gene NFKB1 and prostate carcinoma.